Objective To investigate the long‐term efficacy and safety of gonadotropin‐releasing
hormone analog (GnRHa) treatment in children with idiopathic central precocious puberty …

Abstract The Committee of Central Precocious Puberty of Korean Pediatrics and
Adolescents of the Korean Society of Pediatric Endocrinology has newly developed …

Objective (-)-Epigallocatechin-3-gallate (EGCG) has preventive effects on obesity-related
precocious puberty, but its underlying mechanism remains unclear. The aim of this study …

Background Gonadotropin-releasing hormone analog (GnRHa) is the standard treatment for
children with central precocious puberty (CPP). We assessed efficacy and safety of GnRHa …

This study aimed to explore the potential regulatory pathways of (-)-epigallocatechin-3-
gallate (EGCG) in preventing obesity-related precocious puberty. A retrospective analysis on …

Background The role of dietary intake on precocious puberty remains unclear. This study
aimed to investigate the association between the amount and frequency of dietary intake …

Central precocious puberty (CPP) is due to the premature activation of the hypothalamic–
pituitary–gonadal axis, which is responsible for the appearance of secondary sexual …

This study aims to provide the basis for developing complementary and alternative treatment
approaches for precocious puberty (PP) by examining caregivers' awareness, along with …

Precocious puberty is defined as the onset of puberty before the age of eight years in girls
and before the age of nine years in boys. It is associated with negative physical health …

TORRES-TAMAYO, Margarita et al. Adjuvant interventions in the treatment of precocious
puberty: Clinical guideline for the diagnosis and treatment of precocious puberty. Bol. Med …